Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001787306-25-000013
Filing Date
2025-02-04
Accepted
2025-02-04 20:00:40
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738717233.html 4  
1 FORM 4 wk-form4_1738717233.xml 4 4648
  Complete submission text file 0001787306-25-000013.txt   6261
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 3027 TOWNSGATE ROAD, SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address
Edwards Larry Todd (Reporting) CIK: 0001994805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39186 | Film No.: 25590359